Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Tiedje

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Endocrine|February 12, 2022
Prolonged survival of anaplastic thyroid carcinoma is associated with resectability, low tumor-infiltrating neutrophils/myeloid-derived suppressor cells, and low peripheral neutrophil-to-lymphocyte ratioBin Xu, Lingxin Zhang, Reza Setoodeh, et al.
European Journal of Endocrinology|December 8, 2016
Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in GermanyJulia Wendler, Matthias Kroiss, Katja Gast, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitorsVera Tiedje, Jillian Greenberg, Tianyue Qin, et al.
The Journal of Clinical Investigation|August 19, 2025
Loss of tumor cell MHC Class II drives MAPK-inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancersVera Tiedje, Jillian Greenberg, Tianyue Qin, et al.
Cancer Discovery|December 15, 2020
SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation TherapiesMahesh Saqcena, Luis Javier Leandro-Garcia, Jesper L V Maag, et al.
Scientific Data|December 29, 2024
Comprehensive Mass Spectral Libraries of Human Thyroid Tissues and CellsLu Li, Wenhao Jiang, Wenjun Wei, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
RBM10 loss induces aberrant splicing of cytoskeletal and extracellular matrix mRNAs and promotes metastatic fitnessGnana P Krishnamoorthy, Anthony R Glover, Brian R Untch, et al.
The Journal of Experimental Medicine|February 24, 2025
RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAsGnana P Krishnamoorthy, Anthony R Glover, Brian R Untch, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Targetable treatment resistance in thyroid cancer with clonal hematopoiesisVera Tiedje, Pablo Sánchez Vela, Julie L Yang, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Endocrine|February 12, 2022
Prolonged survival of anaplastic thyroid carcinoma is associated with resectability, low tumor-infiltrating neutrophils/myeloid-derived suppressor cells, and low peripheral neutrophil-to-lymphocyte ratioBin Xu, Lingxin Zhang, Reza Setoodeh, et al.
European Journal of Endocrinology|December 8, 2016
Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in GermanyJulia Wendler, Matthias Kroiss, Katja Gast, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitorsVera Tiedje, Jillian Greenberg, Tianyue Qin, et al.
The Journal of Clinical Investigation|August 19, 2025
Loss of tumor cell MHC Class II drives MAPK-inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancersVera Tiedje, Jillian Greenberg, Tianyue Qin, et al.
Cancer Discovery|December 15, 2020
SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation TherapiesMahesh Saqcena, Luis Javier Leandro-Garcia, Jesper L V Maag, et al.
Scientific Data|December 29, 2024
Comprehensive Mass Spectral Libraries of Human Thyroid Tissues and CellsLu Li, Wenhao Jiang, Wenjun Wei, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
RBM10 loss induces aberrant splicing of cytoskeletal and extracellular matrix mRNAs and promotes metastatic fitnessGnana P Krishnamoorthy, Anthony R Glover, Brian R Untch, et al.
The Journal of Experimental Medicine|February 24, 2025
RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAsGnana P Krishnamoorthy, Anthony R Glover, Brian R Untch, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Targetable treatment resistance in thyroid cancer with clonal hematopoiesisVera Tiedje, Pablo Sánchez Vela, Julie L Yang, et al.
Pageof 2